← ANALYSTS · TIPRANKS

Peter Lawson · Barclays

#602among 12,504 TipRanks analysts★★★★★★★★★★
Hits 47% 233 of 491 ratings made money (TipRanks, all the analyst’s ratings)
Average return of a rating +15.5% Over a year after the rating, TipRanks’ measure
Our companies rated now 10 Buy / hold / sell: 9 / 1 / 0
Upside of the analyst’s targets +257.9% Average over 9 current targets, to the last price
The market’s answer to the ratings −3.0% Day-0 move against SPY in the rating’s direction, average over 1 upgrades, downgrades and target changes
Date · added, NYStockAction RatingPrice target Upside Move vs SPY
Nov 4on TipRanks Nov 5 03:50 TNGXIWMTango Therapeutics · $3.8B Reiterated Buy $13.00 −41.0% +1.2%next day −6.6% · 5 days +3.5%
Nov 4on TipRanks Nov 5 03:50 IDYAIWMIDEAYA Biosciences · $3.3B Reiterated Buy $40.00 +21.8% −1.6%next day −3.0% · 5 days +3.9%
Nov 4on TipRanks 03:20 KPTIIWMKaryopharm Therapeutics · $7M Reiterated Buy $10.00 +2,464.1% −5.7%next day −5.5% · 5 days −4.5%
Nov 3on TipRanks 17:20 GERNIWMGeron · $790M Reiterated Buy — — −3.0%next day −5.6% · 5 days +7.5%
Oct 28on TipRanks Oct 29 03:30 RCUSIWMArcus Biosciences · $2.9B Reiterated Buy $14.00 −36.7% +6.6%next day +2.0% · 5 days +1.5%
Oct 28on TipRanks 03:15 FATEFate Therapeutics · $278M Reiterated Buy $2.00 +11.7% −4.1%next day −10.1% · 5 days −18.4%
Oct 23on TipRanks 04:50 NRIXIWMNurix Therapeutics · $2.7B Reiterated Buy $31.00 +26.9% −2.8%next day +5.8% · 5 days +21.7%
Oct 23on TipRanks 04:50 RVMDRevolution Medicines · $41.5B Reiterated Buy $72.00 −59.5% +0.3%next day +1.1% · 5 days +9.0%
Oct 21on TipRanks 04:10 REPLIWMReplimune Group · $1.1B Reiterated Hold $3.00 −72.4% −9.4%next day +3.0% · 5 days +26.7%
Oct 6on TipRanks 04:25 SDGRIWMSchrodinger · $1.9B Reiterated Buy $25.00 → $24.00−4.0% +6.2% +3.0%next day −4.9% · 5 days −6.2%

Ratings of the stocks the collector reads (the companies of QQQ, SPY, IWM, SMH, SOXL and SOXS and the other US stocks of TipRanks’ feed of new ratings) that it has kept: every new one since 30 September 2026, before that the analyst’s latest rating of each company. Upside is the target over the stock’s last price. The analyst at TipRanks ↗